Cut Through Venture, the premier source for comprehensive Australian startup funding data, has successfully raised an impressive $1,500,000,000 in funding. This significant investment will allow the company to further expand its reach and enhance its suite of services aimed at supporting the Australian startup ecosystem. With initiatives such as angel investing through cutthroughangels.com, a monthly newsletter, and regular events hosted on cutthroughventure.com, as well as insightful content on the State of Australian Startup Funding available at australianstartupfunding.com, Cut Through Venture is poised to continue its mission of empowering startups and investors alike. This substantial funding will enable the company to strengthen its position as a vital player in the Australian startup landscape, providing invaluable resources and expertise to fuel the growth and success of the next generation of innovative ventures.
Cut Through Venture Secures $150 Million Funding: Accelerating Australian Startup Growth
Recently funded 路 $1.5BVenture Capital and Private Equity Principals
Get the full Cut Through Venture company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
